Electrophysiologic effects of E-4031, a new class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
Isomoto
S
S
Third Department of Internal Medicine, Nagasaki University School of Medicine, Japan.
Shimizu
A
A
Konoe
A
A
Kaibara
M
M
Centurion
O A
OA
Fukatani
M
M
Yano
K
K
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D004562:Electrocardiography / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D013617:Tachycardia, Supraventricular / Q000188:drug therapy / Q000503:physiopathology*
D000889:Anti-Arrhythmia Agents; D010880:Piperidines; D011725:Pyridines; C063968:E 4031